12-8847640-G-T
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2
The NM_144670.6(A2ML1):c.1775G>T(p.Arg592Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000644 in 1,613,426 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R592W) has been classified as Uncertain significance.
Frequency
Consequence
NM_144670.6 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| A2ML1 | NM_144670.6 | c.1775G>T | p.Arg592Leu | missense_variant | Exon 15 of 36 | ENST00000299698.12 | NP_653271.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| A2ML1 | ENST00000299698.12 | c.1775G>T | p.Arg592Leu | missense_variant | Exon 15 of 36 | 1 | NM_144670.6 | ENSP00000299698.7 |
Frequencies
GnomAD3 genomes AF: 0.000394 AC: 60AN: 152144Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000382 AC: 95AN: 248816 AF XY: 0.000341 show subpopulations
GnomAD4 exome AF: 0.000670 AC: 979AN: 1461282Hom.: 0 Cov.: 30 AF XY: 0.000623 AC XY: 453AN XY: 726942 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000394 AC: 60AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74322 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Expression in a zebrafish model led to developmental defects including broad forehead, blunted face, and cardiac malformations (Vissers et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24939586, 27942422)
This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 592 of the A2ML1 protein (p.Arg592Leu). This variant is present in population databases (rs200673370, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of Noonan syndrome (PMID: 24939586, 33082526). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 203521). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects A2ML1 function (PMID: 24939586). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not specified Uncertain:1
Variant summary: A2ML1 c.1775G>T (p.Arg592Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00038 in 248816 control chromosomes. The observed variant frequency is approximately 95 fold of the estimated maximal expected allele frequency for a pathogenic variant in A2ML1 causing Noonan Syndrome And Related Conditions phenotype (4e-06), strongly suggesting that the variant is benign. However, c.1775G>T has been reported in the literature in one multi-generation family affected with Noonan Syndrome (Vissers_2015). Co-segregation was seen in all affected family members. This variant has also been reported in one patient with Kabuki syndrome who also carries a de novo pathogenic variant (KMT2D c.4148G>A/p.C1383Y, Long_2016). One functional study in Zebrafish showed that p.S600L (mimicing human p.R592L) caused developmental defects (Vissers_2015). Since the wild-type amino acid in Zebrafish is different to human A2ML1, this result does not allow convincing conclusions about the variant effect. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at